Francois Binette - Feb 13, 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
COO and Executive VP for R&D
Signature
/s/ Francois Binette
Stock symbol
RENB
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 09:44 AM
Previous filing
Oct 27, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to Purchase Common Stock Disposed to Issuer -65K -100% 0 Feb 13, 2024 Common Stock 65K $2.38 Direct F1, F2
transaction RENB Option to Purchase Common Stock Award +65K 65K Feb 13, 2024 Common Stock 65K $1.92 Direct F2
transaction RENB Option to Purchase Common Stock Disposed to Issuer -65K -100% 0 Feb 13, 2024 Common Stock 65K $8.40 Direct F2
transaction RENB Option to Purchase Common Stock Award +65K 65K Feb 13, 2024 Common Stock 65K $1.92 Direct F2
transaction RENB Option to Purchase Common Stock Disposed to Issuer -40K -100% 0 Feb 13, 2024 Common Stock 40K $2.15 Direct F2, F3
transaction RENB Option to Purchase Common Stock Award +40K 40K Feb 13, 2024 Common Stock 40K $1.92 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 60% of the option vested on January 22, 2023 and 40% on July 22, 2023.
F2 The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.
F3 One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025.